User menu

Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia.

Bibliographic reference Tajeddine, Nicolas ; Millard, Isabelle ; Gailly, Philippe ; Gala, Jean-Luc. Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia.. In: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 44, no. 5, p. 548-55 (2006)
Permanent URL http://hdl.handle.net/2078.1/10578
  1. Tajeddine, Cancer Res, 7, 65 (2005)
  2. McElwaine, Br, 8, 125 (2004)
  3. Guerrasio A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E, Parziale A, Marmont F, Diverio D, Divona M, Lo Coco F, Saglio G, Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts, 10.1038/sj.leu.2402478
  4. Wattjes, Leukemia, 13, 8 (2000)
  5. Hosen, Br, 16, 1 (2002)
  6. Gala, Clin Chem, 24, 472 (1998)